Restem
Chemicals & Related Products · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
355 E Rincon St Ste 125, Corona, Califor...Website
www.restem.comRevenue
$7.4 MillionIndustry
About Restem
Restem is a biotechnology company focused on advancing immune health through innovative cell-based therapeutics aimed at treating inflammatory-driven diseases. With a proprietary platform utilizing Umbilical Cord Lining Modified Progenitor Cells (UMPCs) and Activated Natural Killer (NK) Cells, Restem aims to modulate immune responses and support tissue repair. The company has developed a strong intellectual property portfolio and manufacturing capabilities to produce off-the-shelf cellular therapeutics, with ongoing clinical trials for conditions such as Idiopathic Inflammatory Myopathy and Rheumatoid Arthritis. Targeting a global market of over 780 million people suffering from autoimmune diseases, Restem is committed to transforming cutting-edge science into life-changing treatments.Explore more
Restem Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Restem
Compare insights from companies similar to Restem, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Restem Tech Stack
A closer look at the technologies used by Restem
See more technologies
Top Chemicals & Related Products Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Restem
Sign Up For FreeTo access detailed company insights
Restem is a biotechnology company focused on advancing immune health through innovative cell-based therapeutics aimed at treating inflammatory-driven diseases. With a proprietary platform utilizing Umbilical Cord Lining Modified Progenitor Cells (UMPCs) and Activated Natural Killer (NK) Cells, Restem aims to modulate immune responses and support ti... Read More
